Description
An inhibitor of class I HDACs with IC50 values of 0.9, 0.9, 1.2, and >20 μM for recombinant human HDAC 1, 2, 3, and 8, respectively; displays a wide spectrum of antitumor activity, particularly in tumors normally refractory to conventional anticancer agents
Formal name: 4-(acetylamino)-N-(2-aminophenyl)-benzamide
Synonyms: Goe 5549|N-Acetyldinaline|PD 123654|Tacedinaline
Molecular weight: 269.3
CAS: 112522-64-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Deacetylases||Research Area|Epigenetics, Transcription, & Translation|Erasers|Histone Deacetylation